Recombinant CCR2 (Plozalizumab Biosimilar) 抗体
This anti-CCR2 (Plozalizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting CCR2 (Plozalizumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) 抗体 (ABIN7488078)
抗原
CCR2 (Plozalizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Plozalizumab Biosimilar - Anti-CCR2, CD192 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CCR2 (Plozalizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MLN-1202,anti-CCR2,hu1D9
Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation. -
CAS-编号
- 1610761-46-0
抗原
-
You are here:
